vs

Side-by-side financial comparison of BICYCLE THERAPEUTICS PLC (BCYC) and EASTERN CO (EML). Click either name above to swap in a different company.

EASTERN CO is the larger business by last-quarter revenue ($55.3M vs $48.0M, roughly 1.2× BICYCLE THERAPEUTICS PLC). EASTERN CO runs the higher net margin — 1.0% vs -42.0%, a 43.1% gap on every dollar of revenue. On growth, BICYCLE THERAPEUTICS PLC posted the faster year-over-year revenue change (1193.3% vs -22.4%). EASTERN CO produced more free cash flow last quarter ($3.1M vs $-19.9M). Over the past eight quarters, BICYCLE THERAPEUTICS PLC's revenue compounded faster (56.7% CAGR vs -0.6%).

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.

BCYC vs EML — Head-to-Head

Bigger by revenue
EML
EML
1.2× larger
EML
$55.3M
$48.0M
BCYC
Growing faster (revenue YoY)
BCYC
BCYC
+1215.6% gap
BCYC
1193.3%
-22.4%
EML
Higher net margin
EML
EML
43.1% more per $
EML
1.0%
-42.0%
BCYC
More free cash flow
EML
EML
$23.0M more FCF
EML
$3.1M
$-19.9M
BCYC
Faster 2-yr revenue CAGR
BCYC
BCYC
Annualised
BCYC
56.7%
-0.6%
EML

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BCYC
BCYC
EML
EML
Revenue
$48.0M
$55.3M
Net Profit
$-20.2M
$578.9K
Gross Margin
22.3%
Operating Margin
-51.5%
3.1%
Net Margin
-42.0%
1.0%
Revenue YoY
1193.3%
-22.4%
Net Profit YoY
61.1%
103.8%
EPS (diluted)
$-0.29
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCYC
BCYC
EML
EML
Q4 25
$48.0M
Q3 25
$11.7M
$55.3M
Q2 25
$2.9M
$70.2M
Q1 25
$10.0M
$63.3M
Q4 24
$3.7M
$64.3M
Q3 24
$2.7M
$71.3M
Q2 24
$9.4M
$72.6M
Q1 24
$19.5M
$64.6M
Net Profit
BCYC
BCYC
EML
EML
Q4 25
$-20.2M
Q3 25
$-59.1M
$578.9K
Q2 25
$-79.0M
$3.4M
Q1 25
$-60.8M
$1.9M
Q4 24
$1.3M
Q3 24
$-50.8M
$-15.3M
Q2 24
$-39.8M
$3.5M
Q1 24
$-26.6M
$1.9M
Gross Margin
BCYC
BCYC
EML
EML
Q4 25
Q3 25
22.3%
Q2 25
23.3%
Q1 25
22.4%
Q4 24
23.6%
Q3 24
25.5%
Q2 24
25.4%
Q1 24
23.9%
Operating Margin
BCYC
BCYC
EML
EML
Q4 25
-51.5%
Q3 25
-558.6%
3.1%
Q2 25
-2965.8%
4.5%
Q1 25
-703.7%
5.1%
Q4 24
6.1%
Q3 24
-2385.9%
9.5%
Q2 24
-498.3%
8.3%
Q1 24
-162.4%
5.3%
Net Margin
BCYC
BCYC
EML
EML
Q4 25
-42.0%
Q3 25
-503.7%
1.0%
Q2 25
-2703.8%
4.9%
Q1 25
-608.9%
3.1%
Q4 24
2.0%
Q3 24
-1898.4%
-21.5%
Q2 24
-425.3%
4.8%
Q1 24
-136.0%
3.0%
EPS (diluted)
BCYC
BCYC
EML
EML
Q4 25
$-0.29
Q3 25
$-0.85
$0.10
Q2 25
$-1.14
$0.56
Q1 25
$-0.88
$0.32
Q4 24
$0.22
Q3 24
$-0.74
$-2.46
Q2 24
$-0.77
$0.56
Q1 24
$-0.62
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCYC
BCYC
EML
EML
Cash + ST InvestmentsLiquidity on hand
$628.1M
$9.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$610.0M
$124.3M
Total Assets
$717.6M
$220.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCYC
BCYC
EML
EML
Q4 25
$628.1M
Q3 25
$648.3M
$9.2M
Q2 25
$721.5M
$9.1M
Q1 25
$793.0M
$10.2M
Q4 24
$879.5M
$16.1M
Q3 24
$890.9M
$9.7M
Q2 24
$961.4M
$2.0M
Q1 24
$457.0M
$2.1M
Total Debt
BCYC
BCYC
EML
EML
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$42.2M
Q3 24
Q2 24
$30.9M
Q1 24
$30.8M
Stockholders' Equity
BCYC
BCYC
EML
EML
Q4 25
$610.0M
Q3 25
$618.5M
$124.3M
Q2 25
$668.9M
$124.4M
Q1 25
$740.3M
$121.0M
Q4 24
$793.1M
$120.7M
Q3 24
$831.0M
$119.2M
Q2 24
$873.8M
$136.5M
Q1 24
$356.0M
$134.5M
Total Assets
BCYC
BCYC
EML
EML
Q4 25
$717.6M
Q3 25
$764.0M
$220.0M
Q2 25
$832.2M
$229.4M
Q1 25
$883.9M
$232.3M
Q4 24
$956.9M
$235.3M
Q3 24
$996.7M
$244.2M
Q2 24
$1.1B
$255.9M
Q1 24
$547.1M
$253.9M
Debt / Equity
BCYC
BCYC
EML
EML
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.35×
Q3 24
Q2 24
0.04×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCYC
BCYC
EML
EML
Operating Cash FlowLast quarter
$-19.3M
$3.1M
Free Cash FlowOCF − Capex
$-19.9M
$3.1M
FCF MarginFCF / Revenue
-41.5%
5.5%
Capex IntensityCapex / Revenue
1.2%
0.1%
Cash ConversionOCF / Net Profit
5.38×
TTM Free Cash FlowTrailing 4 quarters
$-252.0M
$12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCYC
BCYC
EML
EML
Q4 25
$-19.3M
Q3 25
$-71.2M
$3.1M
Q2 25
$-72.8M
$3.8M
Q1 25
$-86.4M
$-1.8M
Q4 24
$-164.7M
$11.0M
Q3 24
$-39.8M
$-2.9M
Q2 24
$-44.6M
$8.4M
Q1 24
$-70.9M
$2.8M
Free Cash Flow
BCYC
BCYC
EML
EML
Q4 25
$-19.9M
Q3 25
$-71.8M
$3.1M
Q2 25
$-73.3M
$3.0M
Q1 25
$-87.0M
$-2.7M
Q4 24
$-166.0M
$9.0M
Q3 24
$-40.3M
$-7.7M
Q2 24
$-45.0M
$7.3M
Q1 24
$-70.9M
$1.1M
FCF Margin
BCYC
BCYC
EML
EML
Q4 25
-41.5%
Q3 25
-612.3%
5.5%
Q2 25
-2509.7%
4.3%
Q1 25
-871.7%
-4.3%
Q4 24
-4475.7%
13.9%
Q3 24
-1504.7%
-10.8%
Q2 24
-481.2%
10.1%
Q1 24
-362.9%
1.7%
Capex Intensity
BCYC
BCYC
EML
EML
Q4 25
1.2%
Q3 25
5.7%
0.1%
Q2 25
17.1%
1.1%
Q1 25
6.1%
1.3%
Q4 24
33.3%
3.2%
Q3 24
16.3%
6.7%
Q2 24
4.5%
1.5%
Q1 24
0.1%
2.6%
Cash Conversion
BCYC
BCYC
EML
EML
Q4 25
Q3 25
5.38×
Q2 25
1.09×
Q1 25
-0.95×
Q4 24
8.41×
Q3 24
Q2 24
2.40×
Q1 24
1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons